AI Telecom Market M&A and Collaborations; IQSTEL's (IQST) Unique Collaboration Results in Shareholder Dividend

Vancouver, Kelowna, and Delta, British Columbia–(Newsfile Corp. – December 5, 2025) – Investorideas.com, a global news source and expert investing resource covering Telecom and AI stocks, issues a snapshot looking at M&A’s and recent deals in the sector, featuring IQSTEL Inc. (NASDAQ: IQST), a Global Connectivity, AI and Digital Corporation providing advanced solutions across Telecom, […]

Pixalate Releases Q3 2025 Global Made for Advertising (MFA) Benchmarks Report for Mobile Apps

LONDON, Dec. 05, 2025 (GLOBE NEWSWIRE) — Pixalate today released its Q3 2025 Global Made for Advertising (MFA) Mobile Apps Benchmarks Report. This report details open programmatic advertising activity and trends for mobile apps identified by Pixalate as likely MFA across the Google Play Store and Apple App Store in Q3 2025 (September). Key Findings

SFM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sprouts Farmers Market, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / December 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sprouts Farmers Market, Inc. ("Sprouts" or "the Company") (NASDAQ:SFM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Pixalate Releases Q3 2025 Global Made for Advertising (MFA) Benchmarks Report for Mobile Apps

Pixalate Releases Q3 2025 Global Made for Advertising (MFA) Benchmarks Report for Mobile Apps According to Pixalate's MFA research, Pixalate flagged 1,508 mobile apps as likely Made for Advertising (MFA) in Q3 2025, a net increase of 233 apps from Q2 2025 GlobeNewswire December 05, 2025 LONDON, Dec. 05, 2025 (GLOBE NEWSWIRE) — Pixalate today

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

(NasdaqGM:IRIX), MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Sidoti Year-End Virtual Investor Conference. Management is scheduled to present on

Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

(NASDAQ:BMEA), SAN CARLOS, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it presented COVALENT-111 study results at the 23rd WCIRDC which took place December 3-6, 2025 in Los Angeles, California. The data showed durable glycemic

NobleAI Appoints Alex Wang as Chief Executive Officer to Lead Next Phase of Growth and Innovation

SAN FRANCISCO, Dec. 05, 2025 (GLOBE NEWSWIRE) — NobleAI, the leader in practical AI solutions for chemistry and energy, announced the appointment of Alex Wang as Chief Executive Officer, effective immediately. Alex succeeds Sunil Sanghavi, who has transitioned to the company's Board of Directors after leading NobleAI through a key period of technical advancement, market

Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:OCUL), BEDFORD, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to eight newly hired non-executive employees. The awards were made as an inducement material to each recipient's acceptance of employment with Ocular

Koryx Copper Provides Update on Zambia Projects with Definition of Drill Targets at Luanshya West and Completion of Regional Surface Geochemistry at Mpongwe

(TSX-V:KRY),(Namibian:KYX), Highlights: Multiple targets identified and confirmed for drill testing at Luanshya West. Successful drone magnetic survey, in-fill and extension of soil sampling, and pitting programs completed at Luanshya West. First pass regional surface geochemical sampling completed over Mpongwe License. Drill program planned for early 2026 to test targets at Luanshya West. VANCOUVER, British Columbia,

Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom(TM) Platform

(NASDAQ:INMB), Boca Raton, FL, Dec. 05, 2025 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a clinical-stage inflammation and immunology company, announces a recently published overview of future applications and research areas for mesenchymal stromal cell (MSC) therapies, such as INmune's CORDStrom(TM) platform. The article, titled, “Fate and Function of Exogenously

Scroll to Top